ARCT vs JKHY · rev $5.0M vs P/E 30, rev $2.54B
Arcturus Therapeutics Holdings Inc (ARCT) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
ARCT currently screens at market cap $369.4M. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the ARCT and JKHY stock pages for the full models.
Not investment advice.